A previous study linked CK19 expression with the progression of ICC and demonstrated higher CYFRA21–1 serum levels in ICC patients than in those with extrahepatic adenocarcinoma (35). This evidence concerns the gene KRT19 and intrahepatic cholangiocarcinoma.